RemeGen Co (HKSE:09995) PB Ratio : 4.55 (As of May. 11, 2024)

View and export this data going back to 2020. Start your Free Trial

What is RemeGen Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-11), RemeGen Co's share price is HK$31.40. RemeGen Co's Book Value per Share for the quarter that ended in Dec. 2023 was HK$6.91. Hence, RemeGen Co's PB Ratio of today is 4.55.

The historical rank and industry rank for RemeGen Co's PB Ratio or its related term are showing as below:

HKSE:09995' s PB Ratio Range Over the Past 10 Years
Min: 2.37 Med: 4.31 Max: 6.83
Current: 4.55

During the past 6 years, RemeGen Co's highest PB Ratio was 6.83. The lowest was 2.37. And the median was 4.31.

HKSE:09995's PB Ratio is ranked worse than
73.46% of 1311 companies
in the Biotechnology industry
Industry Median: 2.5 vs HKSE:09995: 4.55

During the past 12 months, RemeGen Co's average Book Value Per Share Growth Rate was -32.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -7.40% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of RemeGen Co was -7.40% per year. The lowest was -7.40% per year. And the median was -7.40% per year.

Back to Basics: PB Ratio

RemeGen Co PB Ratio Historical Data

The historical data trend for RemeGen Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co PB Ratio Chart

RemeGen Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

10.90

9.02

5.67

5.42

RemeGen Co Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial									5.67	3.97	-	5.42	-

Competitive Comparison of RemeGen Co's PB Ratio

For the Biotechnology subindustry, RemeGen Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RemeGen Co's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RemeGen Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where RemeGen Co's PB Ratio falls into.

RemeGen Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

RemeGen Co's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	31.40	/	6.908
	=	4.55

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

RemeGen Co (HKSE:09995) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

RemeGen Co PB Ratio Related Terms

Thank you for viewing the detailed overview of RemeGen Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

RemeGen Co (HKSE:09995) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (HKSE:09995) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

REGMF:USA REG:Germany 688331:China

Address

58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN

Website

http://www.remegen.com

RemeGen was established in 2008 and listed on the Hong Kong Stock Exchange in 2020. It is a commercial stage biotech company focused on developing drugs to treat autoimmune disease, cancer, and ophthalmic disease for the China market and potentially the global market, as well. Its core assets are disitamab vedotin (RC48), a HER2-targeting antibody-drug conjugate (ADC) for treating HER2-expressing cancers, and telitacicept (RC18), a BLyS and APRIL targeting bispecific fusion protein for treating various B-cell mediated autoimmune diseases. These drugs received their first approvals in China in 2021 and are both covered on the National Reimbursement Drug List (NRDL).

RemeGen Co (HKSE:09995) Headlines

No Headlines